自2003年以来,汉密尔顿郡就所谓的定价问题起诉胰岛素制造商和药店经理。 Hamilton County sues insulin makers and pharmacy managers over alleged price-fixing since 2003.

汉密尔顿州对主要胰岛素制造商和药店福利管理人员提起了联邦诉讼,包括Eli Lilly、Novo Nordisk、Sanofi、CVS Caremark、Express Scripts和OptumRx,指控他们自2003年以来通过秘密回扣计划和其他反竞争做法串通了胰岛素价格膨胀。 Hamilton County has filed a federal lawsuit against major insulin manufacturers and pharmacy benefit managers, including Eli Lilly, Novo Nordisk, Sanofi, CVS Caremark, Express Scripts, and OptumRx, alleging they colluded to inflate insulin prices since 2003 through secret rebate schemes and other anti-competitive practices. 该诉讼案是在俄亥俄州南区提起的,要求赔偿违反州和联邦法律,包括《RICO法》的行为,并要求赔偿未指明的损害、强制性救济以及县雇员和纳税人承担的费用。 The suit, filed in the Southern District of Ohio, claims violations of state and federal laws, including the RICO Act, and seeks unspecified damages, injunctive relief, and compensation for costs borne by county employees and taxpayers. 该州旨在追究公司的责任,减轻公共卫生方案的长期财政负担,并加入俄亥俄州和其他州境内日益增多的类似法律行动浪潮。 The county aims to hold corporations accountable and reduce long-term financial burdens on public health programs, joining a growing wave of similar legal actions across Ohio and other states.